Search results
Robert A. Sisk, MD, is an ophthalmologist for the Division of Pediatric Ophthalmology at Cincinnati Children's Hospital Medical Center.
- (513) 636-4751
- ophthalmology@cchmc.org
Jan 8, 2024 · Ophthalmologist, Robert Sisk, MD specializes in medical and surgical vitreoretinal diseases including diabetic retinopathy and macular pucker at Cincinnati Eye Institute.
Robert F. Sisk (March 20, 1903 – February 25, 1964) was an American film producer. Sources differ as to his birthplace, with some indicating Maryland and others specifying the unincorporated village of Pokeshaw in the Canadian province of New Brunswick.
Professor of Clinical-Affiliate. Ophthalmology | College of Medicine. Print Full CV. Education/Credentials. Medical Degree: University of Kentucky. Internship: University of Cincinnati. Residency: University of Cincinnati. Fellowship: Bascom Palmer Eye Institute (Retina) Contact Information. Medical Sciences Building. Office 513-984-5133.
- Professional Affiliations
- Education and Training
- Biography
Professor of OphthalmologyDirector of Pediatric Retinal SurgeryDirector of Ophthalmic GeneticsRetinal fellowship
1. Bascom Palmer Eye Institute, Miami, FL, USA
Ophthalmology residency
1. University of Cincinnati, Cincinnati, OH, USA
Internship
1. University of Cincinnati, Cincinnati, OH, USA
Dr. Robert A. Sisk is a Board-Certified Diplomate of the American Board of Ophthalmology and a Fellow of the American College of Surgeons. His peers selected him as one of The Best Doctors in America. Dr. Sisk is actively engaged in clinical research and ophthalmic education. Dr. Sisk is a principal investigator or co-investigator for many FDA-regu...
Robert Sisk Purpose To report the concurrent presentation and management of IQCB1-associated Leber Congenital Amaurosis and NDP-associated Familial Exudative Vitreoretinopathy (FEVR).
Oct 12, 2020 · Dr. Robert Sisk, a retina specialist with Cincinnati Eye Institute, was recently featured on Local 12 talking about a clinical trial with Cincinnati Children’s Hospital to use gene therapy to help patients who have vision loss.